CVS Closes in on Aetna
CVS, which operates the massive Caremark pharmacy benefits manager as well as the CVS drugstore chain, is closing in on a deal to buy Aetna in a deal for more than $66 billion in cash and stock. The Wall Street Journal reported the deal could be announced as early as Monday and would value Aetna at between $200-$205 a share. The deal will make CVS a huge presence in virtually all areas of health care, a scale that it apparently hopes will defend it against the ravages of Amazon, if Jeff Bezos ever fancies a swing at the pharmacy business. Fortune
CVS, which operates the massive Caremark pharmacy benefits manager as well as the CVS drugstore chain, is closing in on a deal to buy Aetna in a deal for more than $66 billion in cash and stock. The Wall Street Journal reported the deal could be announced as early as Monday and would value Aetna at between $200-$205 a share. The deal will make CVS a huge presence in virtually all areas of health care, a scale that it apparently hopes will defend it against the ravages of Amazon, if Jeff Bezos ever fancies a swing at the pharmacy business. Fortune